NFIB_HUMAN
ID NFIB_HUMAN Reviewed; 420 AA.
AC O00712; G3V1P1; H7BYE8; O00166; Q12858; Q5VW29; Q63HM5; Q6ZNF9; Q96J45;
DT 01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT 15-MAR-2004, sequence version 2.
DT 03-AUG-2022, entry version 190.
DE RecName: Full=Nuclear factor 1 B-type;
DE Short=NF1-B;
DE Short=Nuclear factor 1/B;
DE AltName: Full=CCAAT-box-binding transcription factor;
DE Short=CTF;
DE AltName: Full=Nuclear factor I/B;
DE Short=NF-I/B;
DE Short=NFI-B;
DE AltName: Full=TGGCA-binding protein;
GN Name=NFIB;
OS Homo sapiens (Human).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Homo.
OX NCBI_TaxID=9606;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX PubMed=9484777; DOI=10.1038/sj.onc.1201609;
RA Geurts J.M.W., Schoenmakers E.F.P.M., Roijer E., Astroem A.-K., Stenman G.,
RA van de Ven W.J.M.;
RT "Identification of NFIB as recurrent translocation partner gene of HMGIC in
RT pleomorphic adenomas.";
RL Oncogene 16:865-872(1998).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC TISSUE=Foreskin;
RX PubMed=9099724; DOI=10.1074/jbc.272.16.10739;
RA Liu Y., Bernard H.U., Apt D.;
RT "NFI-B3, a novel transcriptional repressor of the nuclear factor I family,
RT is generated by alternative RNA processing.";
RL J. Biol. Chem. 272:10739-10745(1997).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA Phelan M., Farmer A.;
RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN [4]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC TISSUE=Amygdala;
RX PubMed=14702039; DOI=10.1038/ng1285;
RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA Isogai T., Sugano S.;
RT "Complete sequencing and characterization of 21,243 full-length human
RT cDNAs.";
RL Nat. Genet. 36:40-45(2004).
RN [5]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6).
RC TISSUE=Colon epithelium;
RX PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA Wiemann S., Schupp I.;
RT "The full-ORF clone resource of the German cDNA consortium.";
RL BMC Genomics 8:399-399(2007).
RN [6]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX PubMed=15164053; DOI=10.1038/nature02465;
RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA Dunham I.;
RT "DNA sequence and analysis of human chromosome 9.";
RL Nature 429:369-374(2004).
RN [7]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA Hunkapiller M.W., Myers E.W., Venter J.C.;
RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN [8]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC TISSUE=Cervix;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [9]
RP NUCLEOTIDE SEQUENCE [MRNA] OF 20-283.
RX PubMed=7590749; DOI=10.1006/geno.1995.1107;
RA Qian F., Kruse U., Lichter P., Sippel A.E.;
RT "Chromosomal localization of the four genes (NFIA, B, C, and X) for the
RT human transcription factor nuclear factor I by FISH.";
RL Genomics 28:66-73(1995).
RN [10]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND SER-328, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma;
RX PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA Elledge S.J., Gygi S.P.;
RT "A quantitative atlas of mitotic phosphorylation.";
RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN [11]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND SER-333, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma;
RX PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT site occupancy during mitosis.";
RL Sci. Signal. 3:RA3-RA3(2010).
RN [12]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-328 AND SER-333, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Cervix carcinoma;
RX PubMed=23186163; DOI=10.1021/pr300630k;
RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA Mohammed S.;
RT "Toward a comprehensive characterization of a human cancer cell
RT phosphoproteome.";
RL J. Proteome Res. 12:260-271(2013).
RN [13]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Liver;
RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA Ye M., Zou H.;
RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT phosphoproteome.";
RL J. Proteomics 96:253-262(2014).
RN [14]
RP 9AATAD MOTIF.
RX PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT valines and intron reservoirs.";
RL Cell. Mol. Life Sci. 77:1793-1810(2020).
RN [15]
RP FUNCTION, INVOLVEMENT IN MACID, VARIANTS MACID 37-ARG--GLY-420 DEL;
RP 89-ARG--GLY-420 DEL; THR-114; GLU-126; PRO-132 AND LEU-356, AND
RP CHARACTERIZATION OF VARIANTS MACID THR-114; GLU-126; PRO-132 AND LEU-356.
RX PubMed=30388402; DOI=10.1016/j.ajhg.2018.10.006;
RA Schanze I., Bunt J., Lim J.W.C., Schanze D., Dean R.J., Alders M.,
RA Blanchet P., Attie-Bitach T., Berland S., Boogert S., Boppudi S.,
RA Bridges C.J., Cho M.T., Dobyns W.B., Donnai D., Douglas J., Earl D.L.,
RA Edwards T.J., Faivre L., Fregeau B., Genevieve D., Gerard M., Gatinois V.,
RA Holder-Espinasse M., Huth S.F., Izumi K., Kerr B., Lacaze E., Lakeman P.,
RA Mahida S., Mirzaa G.M., Morgan S.M., Nowak C., Peeters H., Petit F.,
RA Pilz D.T., Puechberty J., Reinstein E., Riviere J.B., Santani A.B.,
RA Schneider A., Sherr E.H., Smith-Hicks C., Wieland I., Zackai E., Zhao X.,
RA Gronostajski R.M., Zenker M., Richards L.J.;
RT "NFIB haploinsufficiency is associated with intellectual disability and
RT macrocephaly.";
RL Am. J. Hum. Genet. 103:752-768(2018).
CC -!- FUNCTION: Transcriptional activator of GFAP, essential for proper brain
CC development (PubMed:30388402). Recognizes and binds the palindromic
CC sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters
CC and in the origin of replication of adenovirus type 2. These proteins
CC are individually capable of activating transcription and replication.
CC {ECO:0000269|PubMed:30388402}.
CC -!- SUBUNIT: Binds DNA as a homodimer.
CC -!- INTERACTION:
CC O00712; P08651: NFIC; NbExp=5; IntAct=EBI-10963452, EBI-741360;
CC -!- SUBCELLULAR LOCATION: Nucleus.
CC -!- ALTERNATIVE PRODUCTS:
CC Event=Alternative splicing; Named isoforms=6;
CC Comment=Additional isoforms seem to exist.;
CC Name=1;
CC IsoId=O00712-1; Sequence=Displayed;
CC Name=2;
CC IsoId=O00712-3; Sequence=Not described;
CC Name=3; Synonyms=NFI-B3;
CC IsoId=O00712-2; Sequence=VSP_003545, VSP_003546;
CC Name=4;
CC IsoId=O00712-4; Sequence=VSP_044462;
CC Name=5;
CC IsoId=O00712-5; Sequence=VSP_045065;
CC Name=6;
CC IsoId=O00712-6; Sequence=VSP_054713, VSP_054714;
CC -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC number of yeast and animal transcription factors.
CC {ECO:0000269|PubMed:31375868}.
CC -!- DISEASE: Macrocephaly, acquired, with impaired intellectual development
CC (MACID) [MIM:618286]: An autosomal dominant disorder characterized by
CC postnatal macrocephaly and borderline to mild intellectual disability.
CC Additional variable neurodevelopmental features include muscular
CC hypotonia, motor and speech delay, attention deficit disorder, autism
CC spectrum disorder, and behavioral abnormalities. Some patients present
CC corpus callosum dysgenesis. {ECO:0000269|PubMed:30388402}. Note=The
CC disease is caused by variants affecting the gene represented in this
CC entry.
CC -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000255|PROSITE-
CC ProRule:PRU00436}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U85193; AAB41899.1; -; mRNA.
DR EMBL; U70862; AAB51197.1; -; mRNA.
DR EMBL; BT007266; AAP35930.1; -; mRNA.
DR EMBL; AK131233; BAD18416.1; -; mRNA.
DR EMBL; BX648416; CAH56156.1; -; mRNA.
DR EMBL; BX648845; -; NOT_ANNOTATED_CDS; mRNA.
DR EMBL; AL136366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AL441963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AL137017; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; AL449443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR EMBL; CH471071; EAW58697.1; -; Genomic_DNA.
DR EMBL; CH471071; EAW58699.1; -; Genomic_DNA.
DR EMBL; BC001283; AAH01283.1; -; mRNA.
DR EMBL; U07810; AAA93125.1; -; mRNA.
DR CCDS; CCDS55291.1; -. [O00712-5]
DR CCDS; CCDS6474.1; -. [O00712-1]
DR CCDS; CCDS65007.1; -. [O00712-6]
DR RefSeq; NP_001177666.1; NM_001190737.1. [O00712-5]
DR RefSeq; NP_001177667.1; NM_001190738.1.
DR RefSeq; NP_001269716.1; NM_001282787.1. [O00712-6]
DR RefSeq; NP_005587.2; NM_005596.3. [O00712-1]
DR AlphaFoldDB; O00712; -.
DR SMR; O00712; -.
DR BioGRID; 110853; 135.
DR DIP; DIP-61433N; -.
DR IntAct; O00712; 119.
DR STRING; 9606.ENSP00000370340; -.
DR GlyGen; O00712; 1 site, 1 O-linked glycan (1 site).
DR iPTMnet; O00712; -.
DR PhosphoSitePlus; O00712; -.
DR BioMuta; NFIB; -.
DR EPD; O00712; -.
DR jPOST; O00712; -.
DR MassIVE; O00712; -.
DR MaxQB; O00712; -.
DR PaxDb; O00712; -.
DR PeptideAtlas; O00712; -.
DR PRIDE; O00712; -.
DR ProteomicsDB; 32394; -.
DR ProteomicsDB; 43594; -.
DR ProteomicsDB; 48006; -. [O00712-1]
DR ProteomicsDB; 48007; -. [O00712-2]
DR ProteomicsDB; 65511; -.
DR Antibodypedia; 1309; 221 antibodies from 30 providers.
DR DNASU; 4781; -.
DR Ensembl; ENST00000380953.6; ENSP00000370340.1; ENSG00000147862.18. [O00712-5]
DR Ensembl; ENST00000380959.7; ENSP00000370346.3; ENSG00000147862.18. [O00712-1]
DR Ensembl; ENST00000543693.5; ENSP00000442888.1; ENSG00000147862.18. [O00712-6]
DR GeneID; 4781; -.
DR KEGG; hsa:4781; -.
DR MANE-Select; ENST00000380953.6; ENSP00000370340.1; NM_001190737.2; NP_001177666.1. [O00712-5]
DR UCSC; uc003zld.4; human. [O00712-1]
DR CTD; 4781; -.
DR DisGeNET; 4781; -.
DR GeneCards; NFIB; -.
DR HGNC; HGNC:7785; NFIB.
DR HPA; ENSG00000147862; Low tissue specificity.
DR MalaCards; NFIB; -.
DR MIM; 600728; gene.
DR MIM; 618286; phenotype.
DR neXtProt; NX_O00712; -.
DR OpenTargets; ENSG00000147862; -.
DR PharmGKB; PA31591; -.
DR VEuPathDB; HostDB:ENSG00000147862; -.
DR eggNOG; KOG3663; Eukaryota.
DR GeneTree; ENSGT00950000182916; -.
DR HOGENOM; CLU_061490_0_0_1; -.
DR InParanoid; O00712; -.
DR PhylomeDB; O00712; -.
DR TreeFam; TF313889; -.
DR PathwayCommons; O00712; -.
DR Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR SignaLink; O00712; -.
DR SIGNOR; O00712; -.
DR BioGRID-ORCS; 4781; 25 hits in 1093 CRISPR screens.
DR ChiTaRS; NFIB; human.
DR GeneWiki; NFIB_(gene); -.
DR GenomeRNAi; 4781; -.
DR Pharos; O00712; Tbio.
DR PRO; PR:O00712; -.
DR Proteomes; UP000005640; Chromosome 9.
DR RNAct; O00712; protein.
DR Bgee; ENSG00000147862; Expressed in pericardium and 209 other tissues.
DR ExpressionAtlas; O00712; baseline and differential.
DR Genevisible; O00712; HS.
DR GO; GO:0044300; C:cerebellar mossy fiber; ISS:UniProtKB.
DR GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:UniProtKB.
DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR GO; GO:0140416; F:transcription regulator inhibitor activity; IDA:GO_Central.
DR GO; GO:0021960; P:anterior commissure morphogenesis; ISS:UniProtKB.
DR GO; GO:0007420; P:brain development; IMP:UniProtKB.
DR GO; GO:0060689; P:cell differentiation involved in salivary gland development; IEA:Ensembl.
DR GO; GO:0002062; P:chondrocyte differentiation; ISS:UniProtKB.
DR GO; GO:0060486; P:club cell differentiation; ISS:UniProtKB.
DR GO; GO:0071679; P:commissural neuron axon guidance; ISS:UniProtKB.
DR GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR GO; GO:0002067; P:glandular epithelial cell differentiation; IEA:Ensembl.
DR GO; GO:0010001; P:glial cell differentiation; ISS:UniProtKB.
DR GO; GO:0030902; P:hindbrain development; IEA:Ensembl.
DR GO; GO:0061141; P:lung ciliated cell differentiation; ISS:UniProtKB.
DR GO; GO:0043392; P:negative regulation of DNA binding; IDA:UniProtKB.
DR GO; GO:2000795; P:negative regulation of epithelial cell proliferation involved in lung morphogenesis; ISS:UniProtKB.
DR GO; GO:2000791; P:negative regulation of mesenchymal cell proliferation involved in lung development; ISS:UniProtKB.
DR GO; GO:1902894; P:negative regulation of miRNA transcription; IMP:BHF-UCL.
DR GO; GO:2000647; P:negative regulation of stem cell proliferation; IEA:Ensembl.
DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR GO; GO:0021740; P:principal sensory nucleus of trigeminal nerve development; ISS:UniProtKB.
DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR GO; GO:0060662; P:salivary gland cavitation; IEA:Ensembl.
DR GO; GO:0072089; P:stem cell proliferation; IEA:Ensembl.
DR GO; GO:0060509; P:type I pneumocyte differentiation; ISS:UniProtKB.
DR GO; GO:0060510; P:type II pneumocyte differentiation; ISS:UniProtKB.
DR InterPro; IPR000647; CTF/NFI.
DR InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR PANTHER; PTHR11492; PTHR11492; 1.
DR Pfam; PF00859; CTF_NFI; 1.
DR Pfam; PF03165; MH1; 1.
DR Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR SMART; SM00523; DWA; 1.
DR PROSITE; PS00349; CTF_NFI_1; 1.
DR PROSITE; PS51080; CTF_NFI_2; 1.
PE 1: Evidence at protein level;
KW Activator; Alternative splicing; Disease variant; DNA replication;
KW DNA-binding; Intellectual disability; Methylation; Nucleus; Phosphoprotein;
KW Reference proteome; Transcription; Transcription regulation.
FT CHAIN 1..420
FT /note="Nuclear factor 1 B-type"
FT /id="PRO_0000100195"
FT DNA_BIND 1..195
FT /note="CTF/NF-I"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00436"
FT REGION 189..208
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 252..364
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 377..420
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOTIF 397..405
FT /note="9aaTAD"
FT /evidence="ECO:0000269|PubMed:31375868"
FT COMPBIAS 252..274
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 287..301
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 318..339
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 398..420
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 264
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:18669648"
FT MOD_RES 286
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:P97863"
FT MOD_RES 292
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:24275569"
FT MOD_RES 295
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:24275569"
FT MOD_RES 312
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:20068231,
FT ECO:0007744|PubMed:23186163"
FT MOD_RES 328
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:18669648,
FT ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT MOD_RES 333
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:20068231,
FT ECO:0007744|PubMed:23186163"
FT MOD_RES 335
FT /note="Asymmetric dimethylarginine"
FT /evidence="ECO:0000250|UniProtKB:P97863"
FT MOD_RES 388
FT /note="Asymmetric dimethylarginine"
FT /evidence="ECO:0000250|UniProtKB:P97863"
FT VAR_SEQ 1..252
FT /note="Missing (in isoform 6)"
FT /evidence="ECO:0000303|PubMed:17974005"
FT /id="VSP_054713"
FT VAR_SEQ 1..10
FT /note="MMYSPICLTQ -> MERIPVSVDFWVVCCAVLKCNPGIPMERIPVSVDFWVV
FT CCAVLKCNPGIPKRMSTLCFGFS (in isoform 4)"
FT /evidence="ECO:0000303|PubMed:14702039"
FT /id="VSP_044462"
FT VAR_SEQ 187..188
FT /note="QD -> AR (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:9099724"
FT /id="VSP_003545"
FT VAR_SEQ 189..420
FT /note="Missing (in isoform 3)"
FT /evidence="ECO:0000303|PubMed:9099724"
FT /id="VSP_003546"
FT VAR_SEQ 416..420
FT /note="SWYLG -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITT
FT STEAYTASGTSQANRYVGLSPRDPSFLHQQQLRICDWTMNQNGRHLYPSTSEDTLGITW
FT QSPGTWASLVPFQVSNRTPILPANVQNYGLNIIGEPFLQAETSN (in isoform
FT 6)"
FT /evidence="ECO:0000303|PubMed:17974005"
FT /id="VSP_054714"
FT VAR_SEQ 416
FT /note="S -> PNGSGQVVGKVPGHFTPVLAPSPHPSAVRPVTLSMTDTKPITTSTEA
FT YTASGTSQANRYVGLSPRDPSFLHQQQS (in isoform 5)"
FT /evidence="ECO:0000303|PubMed:17974005"
FT /id="VSP_045065"
FT VARIANT 37..420
FT /note="Missing (in MACID)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081859"
FT VARIANT 89..420
FT /note="Missing (in MACID)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081860"
FT VARIANT 114
FT /note="K -> T (in MACID; significant decrease of GFAP
FT transcriptional activation; dbSNP:rs1554709683)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081861"
FT VARIANT 126
FT /note="K -> E (in MACID; significant decrease of GFAP
FT transcriptional activation; dbSNP:rs1554709662)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081862"
FT VARIANT 132
FT /note="L -> P (in MACID; significant decrease of GFAP
FT transcriptional activation; dbSNP:rs1554709654)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081863"
FT VARIANT 356
FT /note="S -> L (in MACID; likely benign variant; does not
FT affect GFAP transcriptional activation;
FT dbSNP:rs1554639196)"
FT /evidence="ECO:0000269|PubMed:30388402"
FT /id="VAR_081864"
FT CONFLICT 17
FT /note="I -> M (in Ref. 1; AAB41899)"
FT /evidence="ECO:0000305"
FT CONFLICT 37
FT /note="R -> G (in Ref. 4; BAD18416)"
FT /evidence="ECO:0000305"
FT CONFLICT 74
FT /note="S -> F (in Ref. 5; BX648845)"
FT /evidence="ECO:0000305"
FT CONFLICT 198
FT /note="N -> S (in Ref. 4; BAD18416)"
FT /evidence="ECO:0000305"
FT CONFLICT 284
FT /note="S -> R (in Ref. 5; BX648845)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 420 AA; 47442 MW; 0F71635FE9D64FA4 CRC64;
MMYSPICLTQ DEFHPFIEAL LPHVRAIAYT WFNLQARKRK YFKKHEKRMS KDEERAVKDE
LLSEKPEIKQ KWASRLLAKL RKDIRQEYRE DFVLTVTGKK HPCCVLSNPD QKGKIRRIDC
LRQADKVWRL DLVMVILFKG IPLESTDGER LMKSPHCTNP ALCVQPHHIT VSVKELDLFL
AYYVQEQDSG QSGSPSHNDP AKNPPGYLED SFVKSGVFNV SELVRVSRTP ITQGTGVNFP
IGEIPSQPYY HDMNSGVNLQ RSLSSPPSSK RPKTISIDEN MEPSPTGDFY PSPSSPAAGS
RTWHERDQDM SSPTTMKKPE KPLFSSASPQ DSSPRLSTFP QHHHPGIPGV AHSVISTRTP
PPPSPLPFPT QAILPPAPSS YFSHPTIRYP PHLNPQDTLK NYVPSYDPSS PQTSQSWYLG
